Charles Cashion, Director at NovaBay Pharmaceuticals, Inc. (NBY), bought 1,000 shares at $1.90 ($2K) on 2009-08-31, disclosed to the SEC on 2009-08-31.
Open-market purchase of $2k NBY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.